PT-141 represents a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound functions by stimulating specific receptors throughout the body, causing to enhanced sexual function. Preclinical studies have suggested that PT-141 has the potential to remarkably address a range of sex